United Therapeutics Corp (UTHR)
237.04
+1.73
(+0.74%)
USD |
NASDAQ |
Apr 18, 16:00
236.92
-0.12
(-0.05%)
Pre-Market: 20:00
United Therapeutics Total Liabilities (Quarterly): 1.182B for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 1.182B |
| September 30, 2023 | 1.312B |
| June 30, 2023 | 1.270B |
| March 31, 2023 | 1.223B |
| December 31, 2022 | 1.248B |
| September 30, 2022 | 1.219B |
| June 30, 2022 | 1.225B |
| March 31, 2022 | 1.184B |
| December 31, 2021 | 1.210B |
| September 30, 2021 | 1.219B |
| June 30, 2021 | 1.205B |
| March 31, 2021 | 1.196B |
| December 31, 2020 | 1.220B |
| September 30, 2020 | 1.128B |
| June 30, 2020 | 1.126B |
| March 31, 2020 | 1.077B |
| December 31, 2019 | 1.133B |
| September 30, 2019 | 1.284B |
| June 30, 2019 | 1.332B |
| March 31, 2019 | 1.388B |
| December 31, 2018 | 593.20M |
| September 30, 2018 | 700.10M |
| June 30, 2018 | 660.10M |
| March 31, 2018 | 631.60M |
| December 31, 2017 | 758.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 846.90M |
| June 30, 2017 | 896.20M |
| March 31, 2017 | 485.10M |
| December 31, 2016 | 463.40M |
| September 30, 2016 | 419.60M |
| June 30, 2016 | 384.40M |
| March 31, 2016 | 469.30M |
| December 31, 2015 | 584.70M |
| September 30, 2015 | 679.86M |
| June 30, 2015 | 683.26M |
| March 31, 2015 | 782.56M |
| December 31, 2014 | 618.84M |
| September 30, 2014 | 855.49M |
| June 30, 2014 | 739.80M |
| March 31, 2014 | 757.24M |
| December 31, 2013 | 783.26M |
| September 30, 2013 | 619.54M |
| June 30, 2013 | 561.53M |
| March 31, 2013 | 535.77M |
| December 31, 2012 | 531.73M |
| September 30, 2012 | 586.66M |
| June 30, 2012 | 546.80M |
| March 31, 2012 | 536.79M |
| December 31, 2011 | 558.71M |
| September 30, 2011 | 582.08M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
1.077B
Minimum
Mar 2020
1.332B
Maximum
Jun 2019
1.210B
Average
1.219B
Median
Sep 2021
Total Liabilities (Quarterly) Benchmarks
| Liquidia Corp | 71.04M |
| Esperion Therapeutics Inc | 660.79M |
| Vertex Pharmaceuticals Inc | 5.150B |
| Sarepta Therapeutics Inc | 2.405B |
| Heron Therapeutics Inc | 256.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.167B |
| Shareholders Equity (Quarterly) | 5.985B |
| Debt to Equity Ratio | 0.117 |
| Current Ratio | 4.414 |
| Net Debt Paydown Yield | 0.19% |